Protein Distribution and Leucine Supplementation Effects on Body Composition and Performance in Tactical Athletes
The Effect of Protein Distribution and Leucine Supplementation on Body Composition, Physical Performance, and Myofibrillar Damage in Tactical Athletes: a Randomized Controlled Trial During 8 Weeks of Intensive Training
1 other identifier
interventional
69
0 countries
N/A
Brief Summary
This randomized controlled trial will examine the effects of within-day protein distribution and leucine supplementation on body composition, physical performance, and biomarkers of muscle damage in tactical athletes during an 8-week intensive training program. Sixty-nine healthy male participants (18-35 years) enrolled in a Ministry of Defense training course will be randomly assigned to one of three iso-caloric dietary groups providing 1.6 g/kg/day of protein: (1) evenly distributed protein across three meals (EVEN), (2) a 16-hour daily protein fasting pattern with protein concentrated at lunch and dinner (FAST), or (3) the same fasting pattern with 5 g leucine supplementation at breakfast (FAST-RESCUE). Primary outcomes include changes in lean body mass. Secondary outcomes include strength, anaerobic performance, and biochemical markers of muscle damage, including urinary titin N-terminal fragment (UTF). Assessments will be conducted at baseline, Week 5, and Week 8.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
March 2, 2026
February 1, 2026
2.8 years
February 22, 2026
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Lean Body Mass (LBM)
Lean body mass (kg) assessed by multi-frequency bioelectrical impedance analysis (BIA) using the SECA mBCA 515.
Baseline (Week 1) to Week 8
Secondary Outcomes (17)
Change in Fat Mass Percentage
Baseline (Week 1), Week 5, and Week 8
Change in Fat-Free Mass (FFM)
Baseline (Week 1), Week 5, and Week 8
Change in Skeletal Muscle Mass (SMM)
Baseline (Week 1), Week 5, and Week 8
Change in Maximal Strength - Isometric Mid-Thigh Pull (IMTP)
Baseline (Week 1), Week 5, and Week 8
Change in Maximal Voluntary Isometric Contraction (MVC)
Baseline (Week 1), Week 5, and Week 8
- +12 more secondary outcomes
Study Arms (3)
EVEN (Even Protein Distribution)
OTHERParticipants consume an iso-caloric diet providing 1.6 g/kg/day protein, distributed evenly across three daily meals at approximately 08:00, 13:00, and 18:00, with each meal providing \~one-third of daily protein. Participants follow an overnight protein fasting window of approximately 21:00-08:00.
FAST (Protein-Fasting Morning; Protein at Lunch + Dinner)
EXPERIMENTALParticipants consume an iso-caloric diet providing 1.6 g/kg/day protein using a skewed distribution that creates a 16-hour protein-free window (21:00-13:00) by omitting protein at breakfast (breakfast contains carbohydrate and fat only). Daily protein intake is concentrated at lunch and dinner to achieve the total 1.6 g/kg/day target.
FAST-RESCUE (FAST + Leucine at Breakfast)
EXPERIMENTALIdentical dietary pattern to FAST: iso-caloric diet with 1.6 g/kg/day protein, protein-free breakfast, and protein concentrated at lunch and dinner, creating a 16-hour protein-free window (21:00-13:00).
Interventions
Participants ingest 5 g free-form L-leucine at breakfast (\~08:00) daily for 8 weeks. Leucine is provided as unflavored, pharmaceutical-grade instantized powder, reconstituted in water and consumed at the protein-free breakfast meal.
Iso-caloric diet providing 1.6 g/kg/day protein evenly distributed across three daily meals for 8 weeks.
Iso-caloric diet providing 1.6 g/kg/day protein with protein omitted at breakfast and concentrated at lunch and dinner, creating a 16-hour daily protein-free window for 8 weeks.
Eligibility Criteria
You may qualify if:
- Male participants aged 18-35 years
- Enrolled in an active Ministry of Defense tactical training program
- Physically active and medically cleared to participate in intensive training
- Willing and able to comply with the dietary intervention and training protocol
- Provide written informed consent prior to participation
You may not qualify if:
- Musculoskeletal or neuromuscular injury or impairment limiting participation in exercise training
- Cardiopulmonary disease (including recent myocardial infarction or unstable angina)
- History of cancer, diabetes, thyroid disease, hypertension, or chronic renal failure
- Cognitive impairment affecting ability to provide informed consent
- Use of medications that may affect metabolism, muscle physiology, or exercise performance
- Known allergy or intolerance to study dietary components or leucine supplementation
- Non-compliance with study protocol requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Yftach Gepner, PhD
Tel Aviv University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the dietary intervention and differences in meal timing, participants and study personnel responsible for dietary supervision are not blinded to group allocation. Laboratory analyses of biochemical outcomes may be performed without knowledge of group assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator - Professor
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
March 2, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share